RxDoctor Payments Data

George Russell, DO

Family Medicine · Sulphur, OKNPI 1508307448

Payments from drug & device makers

$1,028in general payments, 2019–2025

Across 62 payments — averaging $16.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$283
  • Sumitomo Pharma America, Inc.$151
  • AstraZeneca$108
  • AbbVie$105
  • Novo Nordisk$66
  • Merck$49
  • plus $267 from 11 others

What the payments were for

  • Food & beverage$1,028100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,028 in reported general payments places this provider in the 60th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma

Medicare billing

Part B allowed, 2024
$8,698
Medicare patients
22
Services billed
93

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide93$86,475
EliquisApixaban81$57,220
Trelegy ElliptaFluticasone/Umeclidin/Vilanter45$35,344
MounjaroTirzepatide27$28,094
JanumetSitagliptin Phos/Metformin Hcl22$14,469
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen467$12,574
TradjentaLinagliptin25$11,993
ElmironPentosan Polysulfate Sodium12$11,349
RybelsusSemaglutide12$10,514
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$10,128
Duloxetine Hcl132$9,753
TrulicityDulaglutide11$9,627
TrintellixVortioxetine Hydrobromide17$9,313
Combivent RespimatIpratropium/Albuterol Sulfate13$7,945
Breo ElliptaFluticasone/Vilanterol20$7,472

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$66$96,989105 claims
GSKTrelegy Ellipta, Breo Ellipta$41$42,81665 claims
Lilly USA, LLCMounjaro, Trulicity$283$37,72238 claims
MerckJanumet, Belsomra$49$19,83634 claims
AstraZenecaBreztri Aerosphere$108$10,12816 claims
Sanofi-aventis U.S. LLCLantus$18$3,09416 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,730 family medicine providers in Oklahoma.

Other family medicine in Sulphur

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →